| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 1126.6 | 1437.0 | 650.5 |
| Other income | 6.4 | 3.8 | 1.4 |
| Total income | 1133.0 | 1440.8 | 651.9 |
| Profit before exceptional items & tax | 7.6 | 162.1 | -16.4 |
| Exceptional items | 0.0 | 0.0 | -34.2 |
| Profit before tax | 7.6 | 162.1 | -50.6 |
| Net profit | 5.1 | 118.9 | -52.8 |
| Operating margin | 0.7% | 11.3% | -7.8% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | -95.70% |
|---|---|
| Revenue, year on year | +73.20% |
| Operating profit, year on year | +106.70% |
| Operating profit, quarter on quarter | -99.20% |
NSE results filing, NSE: ZYDUSWELL. Figures extracted from the filing.
Zydus Wellness Ltd: key numbers
- Share price
- ₹498.65
- Market cap
- ₹15,865 Cr
- Revenue (annual)
- ₹3,961 Cr
- Net profit (annual)
- ₹197.2 Cr
- P/E (TTM)
- 84.3×Sector 38.8×
- Promoter holding
- 69.64%+0.00% QoQ
- FII holding
- 3.57%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zydus Wellness Ltd
All →Zydus Wellness Results Update
Zydus Wellness reported Q2 FY27 consolidated net sales of ₹11,227 million, up 74.6% YoY. EBITDA grew 271.7% to ₹855 million on strong brand momentum.
Zydus Wellness Investor Presentation: Key Takeaways
Q2 FY27 deck discloses no group P&L numbers. Brands report double-digit growth (Nutralite, Sugar Free, Complan, Everyuth), Max Protein EBITDA expanded, and no guidance is given.
Zydus Wellness Price Movement Clarification
Zydus Wellness clarified that it received a notice from FSSAI regarding alleged misleading product claims. The company stated that its labels are factual and supported by scientific substantiation.
Zydus Wellness Other Announcement
Zydus Wellness Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Zydus Wellness Management Change
Zydus Wellness Limited announced the resignation of Mr. Arijit Sengupta, Chief Marketing Officer, effective September 18, 2026.
Zydus Wellness Price Movement Clarification
Zydus Wellness clarified to NSE that the spurt in volume is purely market-driven with no undisclosed information. The company confirmed all Reg 30 disclosures have been made.